In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease.   

Links to the B-Cell Breakaway Scouting Reports:

• Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program
• CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program
• STRAP trial, by the Emerging EULAR Network (EMEUNET)

Links to theMednet.org Q&As about this region:

• In the treatment of lupus nephritis, which patients may benefit from the use of rituximab or other B-cell depleting agents during induction?
• What are the potential barriers to the widespread use of obinutuzumab in proliferative lupus nephritis?
• How do you envision incorporating CAR-T therapy into your clinical practice?
• Does synovial biopsy provide diagnostic value in undifferentiated inflammatory arthritis?
  
  

To learn more about RheumMadness:
https://sites.duke.edu/rheummadness/

Subscribe to our newsletter:
https://lists.duke.edu/sympa/subscribe/rheummadness

Find us on social media:
Bluesky: @rheummadness.bsky.social
Instagram: https://www.instagram.com/rheummadness/
X: Follow #RheumMadness


Intro/outro music: Cheery Monday by Kevin MacLeod
Link: https://incompetech.filmmusic.io/song/3495-cheery-monday
License: http://creativecommons.org/licenses/by/4.0/